Association between serum α-tocopherol and serum androgens and estrogens in older men

Nutrition and Cancer

Volumn 35, Issue 1, 1999, Pages 10-15

  Hartman, Terryl J ^a   Dorgan, Joanne F ^a   Virtamo, Jarmo ^b   Tangrea, Joseph A ^a   Taylor, Philip R ^a   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANDROGEN; ANDROSTENEDIONE; BETA CAROTENE; CHOLESTEROL; ESTROGEN; ESTRONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

EID: 0032763601     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S1532791410-15     Document Type: Article

References (41)

1. Benz, CC: Hormone-responsive tumors. In Endocrinology and Metabolism, 3rd ed, P Felig, JD Baxter, and LA Frohman (eds). New York: McGraw-Hill, 1995, pp 1785-1811.
2. The ATBC Cancer Prevention Study Group: The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029-1035, 1994.
3. Heinonen, OP, Albanes, D, Virtamo, J, Taylor, PR, Huttunen, JK, et at.: Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. JNCI 90, 440-446, 1998.
4. Hammond, GL, Kontturi, M, Vihko, P, and Vihko, R: Serum steroids in normal males and patients with prostatic diseases. Clin Endocrinol 9, 113-121, 1978.
5. Ghanadian, R, Puah, CM, and O'Donoghue, EPN: Serum testosterone and dihydrotestosterone in cancer of the prostate. Br J Cancer 39, 696-699, 1979.
6. Saroff, J, Kirdani, Y, Ming Chu, T, Wajsmam, Z, and Murphy, G: Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 37, 46-52, 1980.
7. Ahuwalia, B, Jackson, MA, Jones, GW, Williams, AO, Rao, MS, et al.: Blood hormone profiles in prostate cancer patients in high risk and low risk populations. Cancer 48, 2267-2273, 1981.
8. Drafta, D, Proca, E, Zamfir, V, Schindler, AE, Neacsu, E, et al.: Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J Steroid Biochem 17, 689-693, 1982.
9. Zumoff, B, Levin, J, Strain, GW, Rosenfeld, RS, O'Connor, J, et al.: Abnormal levels of plasma hormones in men with prostate cancer: evidence towards a "two-disease" theory. Prostate 3, 579-588, 1982.
10. Hulka, BS, Hammond, JE, Di Ferdinando, G, Mickey, DD, Fried, FA, et al.: Serum hormone levels among patients with prostate carcinoma or benign prostatic hyperplasia and clinic controls. Prostate 11, 171-182, 1987.
11. de Jong, FH, Oishi, K, Hayes, RB, Bogdanowicz, JFAT, Raatgever, JW, et al.: Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Res 51, 3445-3450, 1991.
12. Nomura, A, Heilbrun, LK, Stemmermann, GN, and Judd, HL: Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 48, 3515-3517, 1988.
13. Barrett-Connor, E, Garland, C, McPhillips, JB, Khaw, KT, and Wingard, DL: A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res 50, 169-173, 1990.
14. Hsing, AW, and Comstock, GW: Seriological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 2, 219-221, 1993.
15. Comstock, GW, Gordon, GB, and Hsing, AW: The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate. Cancer Epidemiol Biomarkers Prev 2, 219-221, 1993.
16. Nomura, A, Stemmermann, GN, Chyou, PH, Henderson, BE, and Stanczyk, FZ: Serum androgens and prostate cancer. Cancer Epidemiol Biomarkers Prev 5, 621-625, 1996.
17. Gann, PH, Hennekens, CH, Ma, J, Longcope, C, and Stampfer, MJ: Prospective study of sex hormone levels and risk of prostate cancer. JNCI 5, 621-625, 1996.
18. Guess, HA, Friedman, GD, Sadler, MC, Stanczyk, FZ, Vogelman, JH, et al.: 5-α-Reductase activity and prostate cancer: a case-control study using stored sera. Cancer Epidemiol Biomarkers Prev 6, 21-24, 1997.
19. Vatten, LJ, Ursin, G, Ross, RD, Stanczyk, FZ, Lobo, RA, et al.: Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus Serum Bank in Norway. Cancer Epidemiol Biomarkers Prev 6, 967-969, 1997.
20. Noble, K: The development of prostate adenocarcinoma in the Nb rat following prolonged sex hormone administration. Cancer Res 37, 1929-1933, 1977.
21. Dorgan, JF, Albanes, D, Virtamo, J, Heinonen, OP, Chandler, DW, et al.: Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland. Cancer Epidemiol Biomarkers Prev 7, 1069-1074, 1998.
22. The ATBC Cancer Prevention Study Group: The α-Tocopherol, β-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4, 1-10, 1994.
23. Milne, DB, and Botnen, J: Retinol, α-tocopherol, lycopene, and α-and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32, 874-876, 1986.
24. SAS Institute: SAS/STAT Software Changes and Enhancements Through Release 6.11: The PHREG Procedure. Cary, NC: SAS Institute, 1996, pp 807-884.
25. SAS Institute: SAS/STAT User's Guide Version 6, 4th ed. Cary, NC: SAS Institute, 1994.
26. Willett, W, and Stampfer, MJ: Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124, 17-27, 1986.
27. El Attar, TM, and Lin, HS: Effect of vitamin C and E on prostaglandin synthesis by fibroblasts and squamous carcinoma cells. Prostaglandins Leukot Essent Fatty Acids 47, 253-257, 1992.
28. Sakamoto, W, Fujie, K, Nishihira, J, Handa, H, Ueda, N, et al.: Effect on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated rat macrophages. Biochim Biophys Acta 1304, 139-144, 1996.
29. 2 level and ornithine decarboxylase activity at the promotion phase of lung tumorigenesis in mice. Biochem Pharmacol 53, 1757-1769, 1997.
30. Yano, Y, Yano, T, Uchida, M, Murakami, A, Ogita, M, et al.: The inhibitory effect of vitamin E on pulmonary polyamine biosynthesis, cell proliferation, and carcinogenesis in mice. Biochim Biophys Acta 1356, 35-42, 1997.
31. Gilbert, VA, Zebrowski, EF, and Chan, AC: Differential effects of mega vitamin E on prostacyclin and thromboxane synthesis in streptozotocin-induced diabetic rats. Horm Metab Res 15, 320-325, 1983.
32. Bhathena, SJ, Berlin, E, Judd, JT, Kim, YC, Law, JS, et al.: Effect of ω-3 fatty acid and vitamin E on hormones involved in carbohydrate and lipid metabolism in men. Am J Clin Nutr 54, 684-688, 1991.
33. Umeda, F, Kato, K-I, Muta, K, and Ibayashi, H: Effect of vitamin E on function of pituitary-gonadal axis in male rats and human studies. Endocrinol Jpn 29, 287-292, 1982.
34. Tsai, AC, Kelley, JJ, Peng, B, and Cook, N: Study on the effect of mega-vitamin E supplementation in man. Am J Clin Nutr 31, 831-837, 1978.
35. Lovejob, JC, Smith, SR, Bray, GA, Veldhuis, JD, Rood, JC, et al.: Effects of experimentally induced mild hyperthyroidism on growth hormone and insulin secretion and sex steroid levels in healthy young men. Metabolism 46, 1424-1428, 1997.
36. Yu, BP: Cellular defenses against damage from reactive oxygen species. Physiol Rev 74, 139-162, 1994.
37. 1 on rat anterior pituitary cyclic AMP and luteinizing hormone release. Prostaglandins 5, 165-171, 1974.
38. Hedge, GA, and Hanson, SD: The effects of prostaglandins on ACTH secretion. Endocrinology 91, 925-933, 1972.
39. Orczyk, GP, and Behrman, HR: Ovulation blockade by aspirin or indomethacin - in vivo evidence for a role of prostaglandin in gonadotrophin secretion. Prostaglandins 1, 3-9, 1972.
40. Hornsby, PJ, and Crivello, JF: The role of lipid peroxidation and biological antioxidant in the function of the adrenal cortex Part 2. Mol Cell Endocrinol 30, 123-147, 1983.
41. Hornsby, PJ: Steroid and xenobiotic effects on the adrenal cortex: mediation by oxidative and other mechanisms. Free Radic Biol Med 6, 103-115, 1989.